Evidence map›Paper›PMID 31618622›Full record

ArticleBehavioural brain research2020

Effects of controlled cortical impact and docosahexaenoic acid on rat pup fatty acid profiles.

Michelle E Schober, Daniela F Requena, J Alan Maschek, James Cox, Leonardo Parra, Alyssa Lolofie

Open access · greenAbstract read
In one paragraph

Article in Behavioural brain research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Michelle E SchoberDepartment of Pediatrics, Division of Critical Care, Salt Lake City, UT, 84132, United States. Electronic address: michelle.schober@hsc.utah.edu.
Daniela F RequenaDepartment of Pediatrics, Division of Critical Care, Salt Lake City, UT, 84132, United States. Electronic address: Daniela.requena@hsc.utah.edu.
J Alan MaschekMetabolomics, Mass Spectrometry and Proteomics Core of the University of Utah, Salt Lake City, UT, 84132, United States. Electronic address: alan.maschek@pharm.utah.edu.
James CoxDepartment of Biochemistry, Salt Lake City, UT, 84132, United States; Diabetes and Metabolism Research Center, Salt Lake City, UT, 84132, United States; Metabolomics, Mass Spectrometry and Proteomics Core of the University of Utah, Salt Lake City, UT, 84132, United States. Electronic address: jcox@cores.utah.edu.
Leonardo ParraDepartment of Biology, Howard Hughes Medical Institute, Salt Lake City, UT, 84132, United States. Electronic address: Leonardo.parra.rivas@gmail.com.
Alyssa LolofieDepartment of Pediatrics, Division of Critical Care, Salt Lake City, UT, 84132, United States. Electronic address: Alyssa.lolofie@hsc.utah.edu.
University of Utah Health Care · USUniversity of Utah · USHoward Hughes Medical Institute · US

Funding

Proteomics CoreU54DK110858 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Anna E Beaudin, JAMES Eric COX · 2016 to 2026
$8.6M
Agilent 6550 QTOF system for U of UtahS10OD016232 · OD · UNIVERSITY OF UTAH · PI COX, JAMES ERIC · 2013 to 2013
$578k
Mechanisms of Docosahexaenoic Acid Neuroprotection after Rat Pup TBIR21NS090098 · NINDS · UNIVERSITY OF UTAH · PI SCHOBER, MICHELLE ELENA · 2015 to 2016
$423k
Agilent 7200 GC/Q-TOF for the University of UtahS10OD021505 · OD · UNIVERSITY OF UTAH · PI COX, JAMES ERIC · 2016 to 2016
$401k
NIDDK NIH HHS U54 DK110858NIH HHS S10 OD016232NIH HHS S10 OD021505NINDS NIH HHS R21 NS090098
6 · The paper itself

Abstract

Traumatic brain injury (TBI) is the leading cause of acquired neurologic disability in children, particularly in those under four years old. During this period, rapid brain growth demands higher Docosahexaenoic Acid (DHA) intake. DHA is an essential fatty acid and brain cell component derived almost entirely from the diet. DHA improved neurologic outcomes and decreased inflammation after controlled cortical impact (CCI) in 17-day old (P17) rats, our established model of pediatric TBI. In adult rodents, TBI decreases brain DHA. We hypothesized that CCI would decrease rat brain DHA at post injury day (PID) 60, blunted by 0.1% DHA diet. We quantitated fatty acids using Gas Chromatography-Mass Spectrometry. We provided 0.1% DHA before CCI to ensure high DHA in dam milk. We compared brain DHA in rats after 60 days of regular (REG) or DHA diet to SHAM pups on REG diet. Brain DHA decreased in REGCCI, not in DHACCI, relative to SHAMREG. In a subsequent experiment, we gave rat pups DHA or vehicle intraperitoneally after CCI followed by DHA or REG diet for 60 days. REG increased brain Docosapentaenoic Acid (n-6 DPA, a brain DHA deficiency marker) relative to SHAMDHA and DHACCI pups (p < 0.001, diet effect). DHA diet nearly doubled DHA and decreased n-6 DPA in blood but did not increase brain DHA content (p < 0.0001, diet effect). We concluded that CCI or craniotomy alone induces a mild DHA deficit as shown by increased brain DPA.

Indexed as

Age FactorsAnimalsBrain Injuries, TraumaticDisease Models, AnimalDocosahexaenoic AcidsFatty Acids, UnsaturatedInfusions, ParenteralMaleNeuroprotective AgentsRatsRats, Sprague-DawleyDocosahexaenoic Acidsdocosapentaenoic acidFatty Acids, UnsaturatedNeuroprotective AgentsDeveloping brainNeuroprotectionNutritionPolyunsaturated fatty acidsTraumatic brain injury

Identifiers

PMID31618622
PMCPMC6897326
OpenAlexW2979960055

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.